{
    "2020-07-24": [
        [
            {
                "time": "",
                "original_text": "二次探底？强势股领跌释放风险“蛮牛变慢牛”",
                "features": {
                    "keywords": [
                        "二次探底",
                        "强势股",
                        "领跌",
                        "释放风险",
                        "蛮牛变慢牛"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：20Q2主动公募医药持仓维持大幅超配状态 重仓集中度有所下降",
                "features": {
                    "keywords": [
                        "医药生物",
                        "20Q2",
                        "主动公募",
                        "超配状态",
                        "重仓集中度下降"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}